Zobrazeno 1 - 5
of 5
pro vyhledávání: '"Moise Kabore"'
Autor:
Benoit Gamain, Eleine Konaté, Alexis Kuppers, Gwenaelle Roguet, Myriam Kanté, Elvira Lopez-Perez, Amadou T. Konaté, Odile Launay, Issiaka Soulama, Moise Kabore, Linda Belarbi, Nicola K. Viebig, Florence Allais, Mathilde Bahuaud, Sodiomon B. Sirima, Cécilia Campion, Désiré Kargougou, Nadine Benhamouda, Amidou Ouedraogo, Arnaud Chêne, Nicolas Havelange, Valérie Boilet, Caroline Roussillon, San Maurice Ouattara, Pierre Loulergue, Rodolphe Thiébaut, Laura Richert, Eric Tartour, Hélène Espérou, Amidou Diarra, Aissata Barry, Odile Leroy, Frédéric Batteux, Alphonse Ouedraogo, Noelie Bere Henry, Issa Nebie, Jean-Philippe Semblat, Sébastien Dechavanne
Publikováno v:
The Lancet Infectious Diseases
The Lancet Infectious Diseases, New York, NY : Elsevier Science ; The Lancet Pub. Group, 2001-, 2020, 20 (5), pp.585-597. ⟨10.1016/S1473-3099(19)30739-X⟩
The Lancet Infectious Diseases, 2020, 20 (5), pp.585-597. ⟨10.1016/S1473-3099(19)30739-X⟩
The Lancet Infectious Diseases, New York, NY : Elsevier Science ; The Lancet Pub. Group, 2001-, 2020, 20 (5), pp.585-597. ⟨10.1016/S1473-3099(19)30739-X⟩
The Lancet Infectious Diseases, 2020, 20 (5), pp.585-597. ⟨10.1016/S1473-3099(19)30739-X⟩
PRIMVAC is a VAR2CSA-derived placental malaria vaccine candidate aiming to prevent serious clinical outcomes of Plasmodium falciparum infection during pregnancy. We assessed the safety and immunogenicity of PRIMVAC adjuvanted with Alhydrogel or gluco
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6aea50e3acd648b0c8aab4deeff22fe5
https://pubmed.ncbi.nlm.nih.gov/32032567
https://pubmed.ncbi.nlm.nih.gov/32032567
Autor:
Issiaka Soulama, Oumar B Traore, Désiré Kargougou, Malick Minkael Sylla, Hamadoun Diakite, Anders Björkman, San Maurice Ouattara, Boubou Sangare, Edith C Bougouma, Amidou Diarra, Harouna Soré, Frederic Nikiema, Sodiomon B. Sirima, Aissata Barry, Aboubacar S Coulibaly, Niawanlou Dara, Abdoul Habib Beavogui, Stéphane Picot, Anyirékun Fabrice Somé, Stephan Duparc, Abdoulaye Djimde, Steffen Borrmann, Ogobara K. Doumbo, Robert M Miller, Amadou H Togo, Samba Coumare, Noelie Henry, Bouran Sidibe, Issaka Sagara, Siaka Goita, Jean-Bosco Ouédraogo, Moise Kabore, Hamma Maiga, Issaka Zongo, José Pedro Gil, Mamadou Saliou Diallo, Jangsik Shin, Mohamed Lamine Alhousseini, Moctar Coulibaly, Bakary Fofana, Hamidou Niangaly, Moussa Djimde, Alassane Dicko, Colin J. Sutherland, Nouhoum Diallo, Isabelle Borghini-Fuhrer, Daouda Camara, Mohamed Keita, Yves D Compaore, Sekou Koumare, Modibo Diarra, Aliou Traore, Souleymane Dama, Amadou Bamadio, Ismaila Thera, Francois Dao
Publikováno v:
The Lancet
The Lancet, Elsevier, 2018, 391 (10128), pp.1378-1390. ⟨10.1016/S0140-6736(18)30291-5⟩
Lancet (London, England)
The Lancet, Elsevier, 2018, 391 (10128), pp.1378-1390. ⟨10.1016/S0140-6736(18)30291-5⟩
Lancet (London, England)
Summary Background Artemether–lumefantrine and artesunate–amodiaquine are used as first-line artemisinin-based combination therapies (ACTs) in west Africa. Pyronaridine–artesunate and dihydroartemisinin–piperaquine are potentially useful for
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::75919a3d04b1b4cc23db33e4cac40681
https://hal-udl.archives-ouvertes.fr/hal-02136477
https://hal-udl.archives-ouvertes.fr/hal-02136477
Autor:
Benjain Sombie, Issiaka Soulama, Maurice S. Ouattara, Alfred B. Tiono, Alphonse Ouedraogo, Sodiomon B. Sirima, Amidou Diarra, Moise Kabore, Issa Nebie
Publikováno v:
BMJ Global Health. 4:A45.2-A45
BackgroundMalaria elimination and its ultimate eradication will require drugs targeting all stages of the parasite’s life cycle. Yet, very few drugs are known to be effective on the sexual stages (gametocytes) of Plasmodium falciparum. Artemisinin-
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::f77273d9b86caefb3252be6c52b93645
https://doi.org/10.1136/bmjgh-2019-edc.119
https://doi.org/10.1136/bmjgh-2019-edc.119
Autor:
Oumar B Traore, Jean-Bosco Ouédraogo, Daouda Camara, Jangsik Shin, Isabelle Borghini-Fuhrer, Ogobara K. Doumbo, Malick Minkael Sylla, Abdoul Habib Beavogui, Issaka Zongo, Steffen Borrmann, Frederic Nikiema, Sodiomon B. Sirima, Aboubacar S Coulibaly, José Pedro Gil, Mamadou Saliou Diallo, Alassane Dicko, Ismaila Thera, Niawanlou Dara, Anyirékun Fabrice Somé, Stephan Duparc, Moise Kabore, Robert M Miller, Issiaka Soulama, Abdoulaye Djimde, Issaka Sagara, Bakary Fofana, Yves D Compaore, Anders Björkman
Publikováno v:
The Lancet. Infectious Diseases
Summary Background Sparse data on the safety of pyronaridine-artesunate after repeated treatment of malaria episodes restrict its clinical use. We therefore compared the safety of pyronaridine-artesunate after treatment of the first episode of malari
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d223048b4d02a8707adcb6d988e9de3a
https://pubmed.ncbi.nlm.nih.gov/26601737
https://pubmed.ncbi.nlm.nih.gov/26601737
Autor:
Alfred B. Tiono, Amidou Diarra, Amidou Ouedraogo, Benjamin Sombie, Alphonse Ouedraogo, Issiaka Soulama, Sodiomon B. Sirima, Daouda Ouattara, Désiré Kargougou, Edith C. Bougouma, Nebie Issa, Maurice S. Ouattara, Souleymane Sanon, Aboubacar S Coulibaly, Moise Kabore
Publikováno v:
BMJ Global Health. 2:A19.3-A20
Background According to the guidelines of the Burkina Faso National Malaria Control Programme, artesunate-amodiaquine (ASAQ) and artemether-lumefantrine (AL) are the first-line drugs for uncomplicated malaria treatments. However, in some contexts whe
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::a79d5225ce4b344744c5cd5b083a1dc1
https://doi.org/10.1136/bmjgh-2016-000260.48
https://doi.org/10.1136/bmjgh-2016-000260.48